Master my poster boy candidate would be Hetlioz (tasimelteon) which is similar to Rozerem and assigned orphan status for Non-24 which affects totally blind people. Patients take 1 tablet a day and it will cost $250 or $7,500 per month. Vanda might have a problem convincing insurances to cover this one.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.